Research Compliance
Simple Ways to Uncover Research Compliance Blind Spots
This webinar offers three strategies to check and reduce blind spots regularly to improve compliance oversight.
Beginner’s Guide to Clinical Trial Billing Compliance
Ensuring proper compliance within clinical trials is confusing, so here are best practices to ensure charges and claims are correctly routed
Local Versus Central IRBs: What’s the Difference?
Local IRBs and central IRBs are not really that different, although sIRB mandates have complicated things for local IRBs.
Clinical Conductor Study Build
Learn how Advarra’s Clinical Conductor Study Build services expedites study activation, saves time, and increases protocol compliance.
Advarra’s Support for Institutions
Find out how we keep site centricity at the forefront through our technology, services, and extraordinary team members.
Planned Emergency Research and Exception from Informed Consent
This white paper outlines considerations for those involved in planning, designing, conducting or reviewing EFIC studies
Beginner’s Guide to Institutional Review Boards (IRBs)
In the U.S., there is an independent group overseeing clinical research, ensuring participants’ rights and welfare are protected.
What Level of Review Does Your Study Need?
In this infographic, we share useful information for investigators to know which level of IRB review likely applies to their study.
Keys to Advancing Your Biotech Go-to-Market Plan
Essential keys for growing biotech companies on navigating the complexities of the FDA 510K filing process.
Medical Devices: “Significant Risk” Versus “Nonsignificant Risk” Determinations
Take a closer look at what significant risk and nonsignificant risk determinations mean for medical device clinical trials.
eSource Study Build Services
Advarra’s eSource Study Build Services delivers high quality study builds and forms in Advarra eSource utilizing best practices in data capture and form design
Ensuring Success with Clinical Development Planning
This white paper describes how to ensure a clinical plan’s feasibility, focusing on issues that matter, and mitigates anticipated program risk.